Sense Labs, Inc. — Form D/A
Sense Labs, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2022-05-09. The offering totals $105.9M, of which $105.9M was reported sold. Industry: Other.
Offering
- Filed: 2022-05-09
- Form: D/A
- Accession: 0001567619-22-009763
- Industry: Other
- Exemptions: 06b
- Total offering: $105.9M
- Amount sold: $105.9M
- Investors: 15
- Date of first sale: 2022-04-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-443482
Issuer
- Name: Sense Labs, Inc.
- CIK: 0001629273
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 485 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02139
- Phone: (617) 844-0955
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Kayode Akinola | Director | Cambridge, MA |
| Dave Grannan | Director | Cambridge, MA |
| Gabriel Kra | Director | Broomfield, CO |
| Lindsay Luger | Director | Washington, DC |
| Michael Mahan | Director | Cambridge, MA |
| Matthew Nordan | Director | Cambridge, MA |
| MICHAEL PHILLIPS | Director | Salt Lake City, UT |
| Jacquelyn Barry Hamilton | Executive Officer | Cambridge, MA |
| MICHAEL PHILLIPS | Executive Officer | Salt Lake City, UT |
| DIPENDER SALUJA | Director | Hayward, CA |
| Izhar Armony | Director | Palo Alto, CA |
| Brian Panoff | Director | CAMBRIDGE, MA |
| Henrik Holland | Director | Cambridge, MA |
| Gabriel M Kra | Director | Cambridge, MA |
| Christopher M Micali | Executive Officer | Cambridge, MA |
| Matthew M Nordan | Director | Cambridge, MA |
Other filings by this issuer (8)
More